| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/07/2009 | US7557204 CUDR as biomarker for cancer progression and therapeutic response |
| 07/07/2009 | US7557200 Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation |
| 07/07/2009 | US7557195 granulocyte colony stimulating factor; provide a homogeneous product and a further purification process using the preparative column is not necessary; 1:1 molar ratio conjugates provide more improved stability and biological activity compared to G-CSF conjugates with several PEGs attached |
| 07/07/2009 | US7557189 Immunoconjugates; screening for antibodies with improved affinity to CD 33 antigen; diagnosis of chronic myeloid leukemia (CML) and promyelocytic leukemia (PML); treating cancer |
| 07/07/2009 | US7557187 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins |
| 07/07/2009 | US7557185 Moraxella catarrhalis proteins |
| 07/07/2009 | US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy |
| 07/07/2009 | US7556940 Assembly of wild-type and chimeric influenza virus-like particles (VLPs) |
| 07/07/2009 | US7556925 Treating or preventing an alpha nu beta 3 integrin mediated disease or disorder; , imaging tissues using positron emission tomography or magnetic resonance imaging, assessing the metastatic characteristics of a tumor, and delivering DNA to a cell |
| 07/07/2009 | US7556920 Polypeptide that forms part of a ubiquitin-ligase complex involved in targeting proteins by ubiquitination for degradation by the proteasome; cancer (breast and prostate carcinoma), immune/inflammatory disease and neurological disease |
| 07/07/2009 | US7556817 Clostridial toxin activatable Clostridial toxins |
| 07/07/2009 | US7556816 Microbiocides, bactericides |
| 07/07/2009 | US7556815 Mutant viral antigen for use in diagnosing hepatitis; immunoassay |
| 07/07/2009 | US7556814 Antigen containing an attenuated strain of human immunodeficient virus; using psoralen and ultraviolet radiation |
| 07/07/2009 | US7556813 Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides |
| 07/07/2009 | US7556812 Purified polypeptide used for eliciting immune response against a West Nile virus associated disease |
| 07/07/2009 | US7556811 Peptide epitopes of apolipoprotein B |
| 07/07/2009 | US7556810 Azurin, pseudoazurin, plastocyanin, rusticyanin, Laz or auracyanin from Xylella, Pseudomonas, Alcaligene, Achromobacter, Bordetella, Methylomonas, Neisseria, or Vibrio; anticarcinogenic or antitumor agents; diabetic retinopathy, rheumatoid arthritis, psoriasis |
| 07/07/2009 | US7556809 Utilizing vascular epithelial growth factor (VEGFR1) polypeptides, fragments and/or encoding oligonucleotides |
| 07/07/2009 | US7556808 Peptide used to inhibit the binding of HIV to cell surface receptor CD4 |
| 07/07/2009 | US7556807 Streptococcus mutans competence stimulating peptide (CSP) which inhibits biofilm formation; dental carries, periodontal disease, gingivitis, and endocarditis; inhibiting dental plaque formation |
| 07/07/2009 | US7556806 High mannose oligosaccharide cluster used to induce an immune response for increasing production of 2G12 antibodies |
| 07/07/2009 | US7556805 Compositions for treatment of melanoma and method of using same |
| 07/07/2009 | US7556804 Monoclonal antibodies which recognize the chain of hepatocyte growth factor receptor (HGF) receptor with the agonist activity of the natural ligand; hybridoma and the antibodies it secretes; inhibiting apoptotic damage to cells ; cardioprotective and hepatoprotective drugs |
| 07/07/2009 | US7556803 Using kappa-myeloma antigen specific immunoglobulins to target and destroy tumor cells; immunotherapy |
| 07/07/2009 | US7556798 Single, breath-activated step of delivering a drug to the pulmonary system by inhaling dry powder particles as carriers for adhered, adsorbed or chemically-combined bioactive agents; 50% of stored particle mass delivered; 5 milligrams of drug delivered; antiagglomerants; asthma; cyctic fibrosis |
| 07/07/2009 | CA2415990C Method for producing biologicals in protein-free culture |
| 07/07/2009 | CA2304255C Hepatitis b virus polypeptides |
| 07/07/2009 | CA2215641C Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulating factor |
| 07/07/2009 | CA2201161C Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/07/2009 | CA2167692C Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 07/02/2009 | WO2009082651A2 Attenuated uracil auxotroph of an apicomplexan and use thereof |
| 07/02/2009 | WO2009082594A2 Secreted/cell bound poxvirus proteins and methods of use thereof as vaccines and anti-viral agents |
| 07/02/2009 | WO2009082440A2 Compositions of toll-like receptor agonists and malaria antigens and methods of use |
| 07/02/2009 | WO2009082002A1 Method of producing japanese encephalitis vaccine stably storable over long time and use of the vaccine |
| 07/02/2009 | WO2009081955A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa |
| 07/02/2009 | WO2009081440A2 Allergens and allergoids from bee venom |
| 07/02/2009 | WO2009081276A2 Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom |
| 07/02/2009 | WO2009081274A2 Mutant forms of streptolysin o |
| 07/02/2009 | WO2009081069A2 Polyclonal antibody directed against the elastin binding protein and method for obtaining same |
| 07/02/2009 | WO2009080934A2 Allergen desensitization method |
| 07/02/2009 | WO2009080933A1 Method and compositions for cutaneous immunisation |
| 07/02/2009 | WO2009080899A2 Products and methods affecting cell and tissue growth |
| 07/02/2009 | WO2009080898A2 Products and methods for preventing tumour growth |
| 07/02/2009 | WO2009080832A1 Methods and agents for improving targeting of cd138 expressing tumor cells |
| 07/02/2009 | WO2009080830A1 Immunoconjugates targeting cd138 and uses thereof |
| 07/02/2009 | WO2009080806A2 Modified influenza virus |
| 07/02/2009 | WO2009080803A1 Vaccines for malaria |
| 07/02/2009 | WO2009080767A1 Fish vaccine |
| 07/02/2009 | WO2009080753A1 Pm-2 antibodies and methods for treating metastasis |
| 07/02/2009 | WO2009080719A1 Vaccine |
| 07/02/2009 | WO2009080715A2 Vaccines for malaria |
| 07/02/2009 | WO2009080447A1 Edible product having an immunostimulating effect |
| 07/02/2009 | WO2009080299A1 Sm-protein based secretion engineering |
| 07/02/2009 | WO2009080254A1 Bivalent, bispecific antibodies |
| 07/02/2009 | WO2009080253A1 Bivalent, bispecific antibodies |
| 07/02/2009 | WO2009080252A1 Bivalent, bispecific antibodies |
| 07/02/2009 | WO2009080251A1 Bivalent, bispecific antibodies |
| 07/02/2009 | WO2009080053A1 Efficient cell culture system for hepatitis c virus genotype 1a and 1b |
| 07/02/2009 | WO2009080052A1 Efficient cell culture system for hepatitis c virus genotype 6a |
| 07/02/2009 | WO2009079922A1 Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof |
| 07/02/2009 | WO2009079796A1 Recombinant rsv antigens |
| 07/02/2009 | WO2009079793A1 Non-aggregating human vh domains |
| 07/02/2009 | WO2009079768A1 Methods of inhibiting tumor growth using ttk antagonists |
| 07/02/2009 | WO2009079731A2 Vaccine comprising toxoplasma gondii surface proteins |
| 07/02/2009 | WO2009053631A3 Method for optimizing blood cell transplants |
| 07/02/2009 | WO2009053629A3 Treatment of tumours using t lymphocyte preparations |
| 07/02/2009 | WO2009052374A3 Igm-mediated receptor clustering and cell modulation |
| 07/02/2009 | WO2009052328A8 Use of mva to treat prostate cancer |
| 07/02/2009 | WO2009030676A3 Pharmaceutical composition comprising a japanese encephalitis virus for vaccination of patients of at least 40 years of age |
| 07/02/2009 | WO2009015284A8 Il-18 receptor antigen binding proteins |
| 07/02/2009 | WO2008156622A8 Humanized antibodies to amyloid beta |
| 07/02/2009 | WO2008058380A8 Cancerous disease modifying antibodies |
| 07/02/2009 | WO2007141005A8 Use of glutamyl aminopeptidase (enpep) as a therapeutic or diagnostic target |
| 07/02/2009 | WO2007134876A8 HIGH AFFINITY HUMAN AND HUMANIZED ANTI-α5β1 INTEGRIN FUNCTION BLOCKING ANTIBODIES WITH REDUCED IMMUNOGENICITY |
| 07/02/2009 | US20090172827 Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases |
| 07/02/2009 | US20090171317 Self-Catheterization Device To Administes Compounds To The Bladder |
| 07/02/2009 | US20090170779 cell adhesion molecule determined to effect platelet aggregation, secretion, platelet spreading and cellular adhesion; thrombosis, atherosclerosis, heart attacks, stroke and other clinical disorders involving thrombus formation |
| 07/02/2009 | US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 07/02/2009 | US20090170162 Non-coiled protective regions of pneumococcal surface proteins pspa and pspc |
| 07/02/2009 | US20090170146 Novel Carboxylesterase Nucleic Acid Molecules, Proteins and Uses Thereof |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 07/02/2009 | US20090169636 Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions |
| 07/02/2009 | US20090169634 DNA vaccine comprising IL-6-encoding DNA construct and applications thereof |
| 07/02/2009 | US20090169628 Article and method for focused delivery of therapeutic and/or diagnostic materials |
| 07/02/2009 | US20090169614 Methods of suppressing microglial activation and systemic inflammatory responses |
| 07/02/2009 | US20090169613 Targeting of tumor stem cells through selective silencing of boris expression |
| 07/02/2009 | US20090169612 Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes |
| 07/02/2009 | US20090169610 Liposome Preparation |
| 07/02/2009 | US20090169609 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 07/02/2009 | US20090169602 Allergy Treatment by Epicutaneous Allergen Administration |
| 07/02/2009 | US20090169582 Recombinant lactobacillus and use of the same |
| 07/02/2009 | US20090169581 Stabilizing formulations for recombinant viruses |
| 07/02/2009 | US20090169580 Attenuated vaccines for non-segmented negative sense rna viruses |
| 07/02/2009 | US20090169579 Modified vaccinia Ankara virus avriant |
| 07/02/2009 | US20090169578 Tolerizing agents |
| 07/02/2009 | US20090169577 immunology; antibodies, immunoglobulins; chronic obstructive pulmonary disease |
| 07/02/2009 | US20090169576 Influenza combinatorial antigen vaccine |
| 07/02/2009 | US20090169575 Proteins |